- ROUNDTABLE: Pharmacy’s future in sync with technology
- EXPERT BLOG: Provider status for pharmacists — one way or another
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Study from NCPA sheds new light on med synchronization programs
ALEXANDRIA, Va., and ST. PAUL, Minn. A White House report encouraging the healthcare system’s transformation to health information technology drew a strong endorsement Tuesday from the nation’s largest electronic prescription network.
The report, titled “The Recovery Act: Transforming the American Economy Through Innovation,” marked the ongoing overhaul of such industries as health care through information technology. Vice President Joe Biden announced some of the report’s findings at a White House gathering of industry leaders in technology and other fields.
Among the guests at that gathering was Harry Totonis, president and CEO of e-prescribing platform provider Surescripts. Totonis, whose company was founded in 2001 by the National Association of Chain Drug Stores and the National Community Pharmacists Association to usher in the digital communications revolution in doctor-prescribed medicines, hailed the Obama Administration’s effort to draw attention to the benefits of e-prescribing and the sharing of medication information.
Those benefits, Totonis said, are “saving lives, time and money, and improving the quality of care.”
Drawing from the report Tuesday, Biden cited the progress of federal and private-sector partnerships with industries including health care, transportation and energy. In a section labeled “Building a Platform for Private Sector Innovation,” the report detailed significant progress with HIT and e-prescribing.
“There is no greater example of what investing in innovation can do for America than health information technology and, more specifically, e-prescribing,” Totonis said. “By providing extensive support for standards testing and adoption and by offering a mix of incentives ... the government has played a leading role in encouraging the adoption of e-prescribing. This, along with the collaboration between Surescripts and the nation’s pharmacies, payers, physicians and technology vendors has produced significant results,” Totonis added.
To wit, Totonis said, “In the last 18 months, e-prescribing has grown from 12% to 32% of all office-based prescribers in the United States, and from 76% to 90% of retail pharmacies.”
However, cautioned Surescripts’ top manager, “e-prescribing and medications are just one component of an overall electronic health record. More innovation is required. We must develop a more efficient, secure and reliable means of sharing a broader set of valued health information for continued, meaningful improvements in care.”